196859-37-7Relevant articles and documents
Xylopyranoside-based agonists of D-myo-inositol 1,4,5-trisphosphate receptors: Synthesis and effect of stereochemistry on biological activity
Rosenberg, Heidi J.,Riley, Andrew M.,Marwood, Rachel D.,Correa, Vanessa,Taylor, Colin W.,Potter, Barry V.L.
, p. 53 - 66 (2007/10/03)
The synthesis of a series of tetrahydrofuranyl α- and β-xylopyranoside trisphosphates, designed by excision of three motifs of adenophostin A is reported. The synthetic route features improved preparations of allyl α-D-xylopyranoside and its 2-O-benzyl ether, and gives access to four diastereoisomeric trisphosphates, which show a range of abilities to mobilise Ca2+ from the intracellular stores of hepatocytes. A comparison of the potencies of the four trisphosphates provides useful information relating to the effects of stereochemical variation on the recognition of carbohydrate-based trisphosphates by D-myo-inositol 1,4,5-trisphosphate receptors. 1-O-[(3′S,4′R)-3-hydroxytetrahydrofuran-4-yl] α-D-xylopyranoside 3,4,3′-trisphosphate (8) is the most active member of the series with a potency close to Ins(1,4,5)P3; a β-linked analogue, 1-O-[(3′R,4′S)-3-hydroxytetrahydrofuran-4-yl] β-D-xylopyranoside 3,4,3′-trisphosphate, is ca. 20-fold weaker than Ins(1,4,5)P3, and the other compounds are much less active. While no compound attained a potency close to that of adenophostin A, we believe that 8 represents the minimal structure for potent Ca2+-releasing activity in this type of carbohydrate-based analogue.
Total synthesis, from D-xylose, of chiral, ring-contracted 1D-myo-inositol 1,4,5-trisphosphate and 1,3,4,5-tetrakisphosphate analogues with C-2 excised
Jenkins, David J.,Potter, Barry V. L.
, p. 41 - 50 (2007/10/03)
A route to chiral, cyclopentane-based congeners of the second messenger 1D-myo-inositol 1,4,5-trisphosphate and its enigmatic metabolite 1D-myo-inositol 1,3,4,5-tetrakisphosphate, starting from D-xylose, is described.Reaction of allyl α-D-xylopyranoside 7 with 2,2,3,3-tetramethoxybutane gave a 1:1 mixture of the 2,3- and 3,4-butanediacetal-protected derivatives 8 and 9.The latter was converted in four steps into 2-O-benzyl-3,4-bis-O-(p-methoxybenzyl)-D-xylopyranose 15, which on reduction with sodium borohydride gave 2-O-benzyl-3,4-bis-O-(p-methoxybenzyl)-D-xylitol 16.Swern oxidation followed by samarium(II) iodide-mediated pinacol coupling gave a 1:3 mixture of 1L-1,2,3,4/5-1-benzyloxy-2,3-dihydroxy-4,5-bis-(p-methoxybenzyloxy)cyclopentane 18 and 1L-1,2,4/3,5-3-benzyloxy-1,2-dihydroxy-4,5-bis-(p-methoxybenzyloxy)cyclopentane 19.The identity of the latter was confirmed by conversion into known compounds, and further elaboration gave the target compounds, 1D-1,2,4/3,5-cyclopentanepentaol 1,3,4-trisphosphate 5 and 1D-1,2,4/3,5-cyclopentanepentaol-1,2,3,4-tetrakisphosphate 6.